Bronchoscopic intratumoral chemotherapy of lung cancer

Lung Cancer

Volumn 61, Issue 1, 2008, Pages 1-12

  Celikoglu, Firuz ^a   Celikoglu, Seyhan I ^a   Goldberg, Eugene P ^b  

^a ISTANBUL UNIVERSITY   (Turkey)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

Endobronchial chemotherapy; Interventional bronchology; Intratumoral chemotherapy; Intratumoral cisplatin injection; Loco regional lung cancer treatment; Lung cancer

Indexed keywords

ADRENALIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; METHOTREXATE; MITOMYCIN C; MITOXANTRONE;

ABSENCE OF SIDE EFFECTS; ATELECTASIS; BRACHYTHERAPY; BRONCHOSCOPE; CANCER RADIOTHERAPY; CANCER RECURRENCE; COMBINATION CHEMOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; DRUG DELIVERY SYSTEM; HEMOSTASIS; HUMAN; IMMUNE RESPONSE; LASER SURGERY; LUNG CANCER; LUNG NON SMALL CELL CANCER; NEPHROTOXICITY; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME; YAG LASER;

ANTINEOPLASTIC AGENTS; BRONCHOSCOPY; HUMANS; INJECTIONS, INTRALESIONAL; LUNG NEOPLASMS;

EID: 45649084306     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2008.03.009     Document Type: Review

References (89)

1. Jemal A., Murray T., Ward E., Samuel A., Tiwari R.C., Ghafour A., et al. Cancer statistics 2005. CA Cancer J Clin 55 (2005) 10-30
2. Cersosomo R.J. Lung cancer: a review. Am J Health Syst Pharm 59 (2002) 611-642
3. Matthews M.J. Problems in morphology and behavior of bronchopulmonary malignant disease. In: Israel L., and Chahinian A.P. (Eds). Lung cancer: natural history, prognosis and therapy (1976), Academic Press, New York 23-62
4. Group L.L.C.S. Patterns of failure in patients with resected stage I and II non-small-cell carcinoma of the lung. Ann Surg 205 (1987) 67-71
5. Kotlyarov E.V., and Rukosuyev A.A. Long-term results and patterns of disease recurrence after radical operations for lung cancer. J Thorac Cardiovasc Surg 102 (1991) 24-28 [Abstract]
6. Noppen M., Meysman M., D'Haese J., Schlesser M., and Vincken W. Interventional bronchoscopy: 5-year experience at the Academic Hospital of the Vrije Universiteit Brussel (AZ-VUB). Acta Clin Belg 52 (1997) 371-380
7. Ries LAG, Kosary CL, Hankey BF, Miller BA, Clegg L, Edwards BK, editors. SEER Cancer Statistics Review, Vol. NIH Pub. No. 97-2789. NIH Bethesda; 1997.
8. Ayers M.L., and Beamis Jr. J.F. Rigid bronchoscopy in the twenty-first century. Clin Chest Med 22 (2001) 355-364
9. Ginsberg R.J., Vokes E.E., and Ruben A. Non-small cell lung cancer. In: De Vita V.T., Hellman S., and Rosenberg S.A. (Eds). Cancer: principles and practice of oncology. 5th ed. (1997), JB Lippincott-Raven, Philadelphia 858-911
10. Luomanen R.K.J., and Watson W.L. Autopsy findings. In: Watson W.L. (Ed). Lung cancer. A study of five thousand memorial hospital cases (1968), CV Mosby Co., St. Louis, Mo 504-510
11. Freitag L., Macha H.-N., and Loddenkemper R. Interventional bronchoscopic procedures. Eur Respir Monogr 17 (2001) 272-304
12. Roswit B., Patno M.E., Rapp P., Veinbergs A.S., Feder B., et al. Survival of patients with inoperable lung cancer: a large scale randomized study of radiation therapy versus placebo. Radiology 90 (1968) 688-697
13. Perez C.A., Stanley K., Rubin P., Kramer S., Brady L., Perez-Tamayo R., et al. A prospective randomized study of various irradiation doses and fractionation schedules in the treatment of inoperable non-oat cell carcinoma of the lung. Cancer 45 (1980) 2744-2753
14. Petrowich Z., Stanley K., Cox J.D., and Paig C. Radiotherapy in the management of locally advanced lung cancer of all cell types. Cancer 48 (1981) 1335-1340
15. Perez C.A., Stanley K., Grundy G., Hanson W., Rubin P., Kramer S., et al. Impact of irradiation technique and tumor control and survival of patients with unresectable nonoat cell carcinoma of the lung: report by the radiation therapy oncology group. Cancer 50 (1982) 1091-1099
16. Kjaer M. Radiotherapy of squamous, adeno and large cell carcinoma of the lung. Cancer Treat Rev 9 (1982) 1-20
17. Chetty K.G., Moran E.M., Sasson C.S.H., Viravathana T., and Light R.W. Effect of radiation therapy on bronchial obstruction due to bronchogenic carcinoma. Chest 95 (1989) 582-584
18. Trovo M.G., Minatel E., Veronesie A., Roncadin M., De Paoli A., Franchin G., et al. Combined radiotherapy and chemotherapy vs. radiotherapy alone in locally advanced bronchogenic carcinoma: a randomized study. Cancer 65 (1990) 400-404
19. Trovo M.G., Minatel E., Franchin G., Boccieri M.G., Nascimben O., Bolzicco G., et al. Radiotherapy (RT) versus RT enhanced by cisplatin (CDPG) in stage III non-small-cell lung cancer (NSCLC): randomized cooperative study. Lung Cancer 7 Suppl. (1991) 158
20. Shaake-Koning C., van den Bogaert W., Dalesio O., Festen J., and Hoogenhout J. Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer. N Engl J Med 326 (1992) 524-530
21. Shaake-Konig C., van den Bogaert W., Daleiso O., Festen J., and Hoogenhout J. Radiosensitization by cytotoxic drugs. The EORTC experience by radiotherapy and lung cancer cooperative groups. Lung Cancer 10 Suppl. (1994) S263-S270
22. Pradier O., Laderer K., Hille A., Weiss E., Christinsen H., and Schmidberger. Concurrent lowdose cisplatin and thoracic radiotherapy in patients with inoperable stage III non-small cell lung cancer: a phase II trial reference to the hemoglobin level as prognostic parameter. J Cancer Res Clin Oncol 131 (2005) 261-269
23. Cortese D.A., and Edell E.S. Role of phototherapy, laser therapy, brachytherapy, prosthetic stents in the management of lung cancer. Clin Chest Med 14 (1993) 149-159
24. Ernst A., Feller-Kopman D., Becker H.D., and Mehta A.C. Central airway obstruction. Am J Respir Crit Care Med 169 (2004) 1278-1297
25. Freitag L., Ernst A., Thomas M., Prenzel R., Wahlers B., and Macha H.-N. Sequential photodynamic therapy (PDT) and high dose brachytherapy for endobronchial tumor control in patients with limited bronchogenic carcinoma. Thorax 59 (2004) 790-793
26. Kato H., Konaka C., Ono J., Kawate N., Nishimaya K., et al. Preoperative laser photodynamic therapy in combination with operation in lung cancer. J Thorac Cardiovasc Surg 90 (1985) 420-429
27. Sutedja T.G., Codrington H., Risse E.K., Breuer H., van Mourik J.C., et al. Auto fluorescence bronchoscopy improves staging of radiographically occult lung cancer and has an impact on therapeutic strategy. Chest 120 (2001) 1327
28. Yuka M., Miyazava T., Kurimoto N., Iwamoto Y., Kanoh K., et al. Endobronchial ultrasonography in the assessment of centrally located early-stage lung cancer before photodynamic therapy. Am J Respir Crit Care Med 165 (2002) 832-837
29. Yasufuku K., Chiyo M., Koh E., Moriya Y., Iyoda A., et al. Endobronchial ultrasound guided transbronchial needle aspiration for staging of lung cancer. Lung Cancer 50 (2005) 347-354
30. Dumon J.R., Shapshay S., Boureceau J., Cavaliere S., Meric B., Garbi N., et al. Neodyum: YAG laser in bronchology. Chest 86 (1984) 163-168
31. Dumon J.R., Reboud E., Garbe L., Autocompte F., and Meric B. Treatment of tracheobronchial lesions by photo-resection. Chest 81 (1982) 278-284
32. Gelb A.F., and Epstein J.D. Laser in treatment of lung cancer. Chest 86 (1984) 662-666
33. Kvale P.A., Eichenhorn M.S., Radke J.R., and Miks V.M. YAG laser photoresection of lesions obstructing the central airways. Chest 87 (1985) 283-288
34. Joyner L.R., Maran A.G., Sarama R., and Yakaboski A. Neodymium YAG laser treatment of intrabronchial lesions. Chest 87 (1985) 428-527
35. Homasson J.P., Renault P., Angebault M., Bonniot, and Bell N.J. Bronchoscopic cryotherapy for airway strictures caused tumors. Chest 90 (1986) 159
36. Ross D.J., Mohsenifar Z., and Koerner S.K. Survival characteristics after neodymium YAG laser photoresection in advanced stage lung cancer. Chest 98 (1990) 581-585
37. Desai S.J., Mehta A.C., Medendorp S.V., Golish J.A., and Ahmad M. Survival experience following Nd YAG laser photoresection for primary bronchogenic carcinoma. Chest 94 (1988) 939-944
38. Cavaliere S., Foccoli P., and Farina P.L. Nd YAG laser bronchoscopy: a five year experience with 1396 experience with 1396 applications in 1000 patients. Chest 94 (1988) 15-21
39. Brutinel W.M., Cortese D.A., Mc Dougall J.G., Gillio R.C., and Bergstrahl E.J. A two-year experience with the neodymium YAG laser in endobronchial obstruction. Chest 91 (1987) 159-165
40. Eicherhorn M.S., Kvale P.A., Miks V.M., Seydel H.G., Horowitz B., and Radke J.R. Initial combination therapy with YAG laser photoresection irradiation for inoperable carcinoma of the lung: a preliminary report. Chest 89 (1986) 782-785
41. Vergnon J.M., Schmitt T., Alamartine E., Barthalemy J.C., Fournet P., and Emonot A. Initial combined cryotherapy and irradiation for unresectable non-small cell lung cancer. Chest 102 (1992) 1436-1440
42. Vincent R.G., Dougherty T.J., Rao U., Boyle D.G., and Potter W.R. Photoradiation therapy in advanced carcinoma of the trachea and bronchus. Chest 85 (1984) 29-33
43. Macha H.N., and Freitag L. The role of brachytherapy in the treatment and control of central bronchial carcinoma. Monaldi Arch Chest Dis 51 (1996) 325-328
44. Furuse K., Fukuoka M., Kato H., et al. A perspective phase II study on photodynamic therapy with Photofrin II for centrally located early-stage lung cancer. J Clin Oncol 11 (1993) 1852-1857
45. Celikoglu S.I., Karayel T., Demirci S., Celikoglu F., Serdengecti S., et al. Direct injection of several anticancer drugs into endobronchial malignant tumor in the palliation of major airway obstruction. Eur Respir J 4 Suppl. 14 (1991) 303S
46. Celikoglu S.I., Celikoglu F., Karayel T., Demirci S., and Cagatay T. Direct injection of anticancer drugs into endobronchial tumors for major airway obstruction. Post Grad Med J 73 (1997) 159-162
47. Celikoglu F., and Celikoglu S.I. Intratumoral chemotherapy with 5-fluorouracil for palliation of bronchial cancer in patients with severe airway obstruction. J Farm Pharmacol 55 (2003) 1441-1448
48. Celikoglu S.I., Celikoglu F., and Goldberg E.P. Intratumoral chemotherapy through a flexible bronchoscope. J Bronchol 11 (2004) 260-265
49. Celikoglu F., Celikoglu S.I., York A.M., and Goldberg E.P. Intratumoral administration of cisplatin through a bronchoscope followed by irradiation for treatment of inoperable non-small cell obstructive lung cancer. Lung Cancer 51 (2006) 225-236
50. Celikoglu S.I., Celikoglu F., and Goldberg E.P. Endobronchial intratumoral chemotherapy (EITC) followed by surgery in early non-small-cell lung cancer with polypoid growth causing erroneous impression of advanced disease. Lung Cancer 54 (2006) 339-346
51. Dasgupta A., Mehta A.C., and Wang K.P. Transbronchial needle aspiration. Semin Respir Crit Care Med 18 (1997) 571-581
52. Annema J.T., Veselic M., and Rabe K.F. Analysis of subcarinal lymph nodes in (suspected) non-small-cell lung cancer a negative transbronchial needle aspiration-What's next? A preliminary report. Respiration 71 (2004) 630-634
53. Seymour C.W., Krimsky W.S., Sager J., Kruklitis J., Lund M.E., et al. Transbronchial needle injection: a systemic review of a new diagnostic and therapeutic paradigm. Respiration 73 (2006) 78-89
54. Wagai F., Kinoshita M., Watanabe R.S.H., and Kitamura S. The direct injection of several anti-cancer drugs into the primary lung cancer through a fiberoptic bronchoscope. Jpn J Thorac Dis 20 (1982) 170
55. Liu M., Ma P., and Lu Z. Local chemotherapy by fibrobroncoscopy for advanced broncogenic carcinoma. Chin J Tuberc Respir Dis 23 (2000) 550-551
56. McLaughlin C.A., and Goldberg E.P. Targeted drugs. In: Goldberg E.P. (Ed). Local chemo- and immunotherapy by intratumor drug injection: opportunities for polymer drug compositions (1983), Wiley Interscience, NY 231-268 [Chapter 10]
57. Goldberg E.P., Hadba A.R., Almond B.A., and Marotta J.S. Intratumoral cancer chemotherapy and immunotherapy: opportunities for non-systemic preoperative drug delivery. J Pharm Pharmacol 54 (2002) 159-180
58. Hayata Y., Ohbo K., Ogava I., and Taira O. Immunotherapy for lung cancer cases using BCG or BCG cell-wall skeleton: intratumoral injections. Gann Monogr Cancer Res 21 (1978) 151-160
59. Kuerer H.M., Newman L.A., Smith T.L., Ames F.C., Hunt K.K., et al. Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy. J Clin Oncol 17 (1999) 460-469
60. Kuerer H.M., Sahin A.A., Hunt K.K., Newman L.A., Brreslin T.M., et al. Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy. Ann Surg 230 (1999) 72-78
61. Livraghi T., Bajetta E., Matricardi L., Villa E., Lovati R., and Vettori C. Fine needle percutaneous intratumoral chemotherapy under ultrasound guidance: a feasibility study. Tumori 72 (1986) 81-87
62. Farrés M.T., de Baere T., Lagrange C., Ramirez L., Rougier P., Munck J.-N., et al. Percutaneous Mitoxantrone injection for primary and secondary liver tumors: preliminary results. CardioVasc Interv Radiol 21 (1998) 399-403
63. Duvillard C., Romanet P., Cosmidis A., Beaudouin N., and Chauffert B. Phase 2 study of intratumoral cisplatin and epinephrine treatment for locally recurrent head and neck tumors. Ann Otol Rhinol Laryngol 113 (2004) 229-233
64. Kitamura K., Takahashi T., Miyagaki T., Yamaoka N., Tsurumi H., et al. Efficacy and specificity of a monoclonal antibody-drug conjugate in chemotherapy by intratumoral injection. Cancer Sci 83 (1992) 769-774
65. Jacobs J.J., Sparendam D., and Den Otter W. Local interleukin 2 therapy is most effective against cancer when injected intratumorally. Cancer Immun Immunother 54 (2005) 647-654
66. Zvarych Iu M., and Shevchenko A.I. Intratumoral chemotherapy in the treatment of regional widespread pulmonary cancer. Klin Khir 9 (2003) 32-33
67. Larsen S.S., Pedersen J.J., Krasnik M., and Jensen T.S. Neoadjuvant chemotherapy in nonsmall-cell lung cancer. Ugeskr Laeger 161 (1999) 6169-6173
68. Felip E., and Rosell R. Is the evidence in favor of neoadjuvant chemotherapy in stage IIIA (N2) non-small cell lung cancer solid enough?. Monaldi Arch Chest Dis 55 (2000) 305-310
69. Primeau A.J., Rendon A., Hedley D., Lilge L., and Tannock I.F. The distribution of the anticancer drug doxorubicin in relation to blood vessels in solid tumors. Clin Cancer Res 11 (2005) 8782-8788
70. Smith J.P., Kanekal S., Montesa B., Patawaran M.B., Chen J.Y., et al. Drug retention and distribution after intratumoral chemotherapy with fluorouracil/epinephrine gel in human pancreatic cancer xenografts. Cancer Chemother Pharmacol 44 (1999) 267-274
71. Monga S.P.S., Wadleigh R.W., Sharma A., Adib H., Strader D., Singh G., et al. Intratumoral therapy of cisplatin/epinephrine injectable gel for palliation in patients with obstructive esophageal cancer. Am J Clin Oncol (CCT) 23 4 (2000) 386-392
72. Lammers T., Peschke P., Kühnlein R., Subr V., Ulbrich K., et al. Effect of intratumoral injection on the biodistribution and the therapeutic potential of HPMA copolymer-based drug delivery systems. Neoplasia 8 (2006) 788-795
73. Cheung R.Y., Rauth A.M., and Yu Wu X. In vivo efficacy and toxicity of intratumorally delivered mytomycin C with doxorubicin usin microsphere formulations. Anti-Cancer Drugs 16 (2005) 423-433
74. Almond B.A., Hadba A.R., Freeman S.T., Cuevas B.J., York A.M., et al. Efficacy of mitoxantrone-loaded albumin microspheres for intratumoral chemotherapy of breast cancer. J Control Release 91 (2003) 147-155
75. Goldberg E.P., Almond B.A., Hadba A.R., Cuevas B.J., York A., et al. Nano-mesosphere drug carriers for localized cancer chemotherapy. Proc NSTI Nanotech 2 (2006) 1-4
76. Tiffet O., Nicholson A.G., Khaddag, Ladas G., Dubois F., and Goldstraw P. Feasibility of detection of sentinel lymph node in peripheral non-small lung cancer with radio isotopic and blue dye techniques. Chest 127 (2005) 443-448
77. Wu J., Ohta Y., and Minato H. Nodal occult metastasis in patients with peripheral lung adenocarcinoma of 2.0 cm or less in diameter. Ann Thorac Surg 71 (2001) 1772-1778
78. Izbicki J.R., Passlick B., Hosch S.B., et al. Mode of spread in the early phase of lymphatic metastasis in non-small cell lung cancer: significance of nodal metastasis. J Thorac Cardiovasc Surg 112 (1996) 623-630
79. Baitchev G., Gorchev G., Deliisky T., Popovska S., and Raitcheva T.Z. Perioperative locoregional application of mitoxantron in patients with early breast carcinoma. J Chemother 13 (2001) 440-443
80. Lardinois D., Brack T., Gaspert A., Spahr T., Schneiter D., et al. Bronchoscopic radioisotope injection for sentinel lymph-node mapping in potentially resectable nonsmall-cell-lung-cancer. Eur J Cardio-Thorac Surg 23 (2003) 824-827
81. Harper E., Dang W., Lapidus R.G., and Garver Jr. R.I. Enhanced efficacy of a novel controlled release paclitaxel formulation (paclimer delivery system) for local-regional therapy of lung cancer tumor nodules in mice. Clin Cancer Res 5 (1999) 4242-4248
82. Sandler A.B., Nemunaitis J., Nemunaitis J., Denham C., von Pawel J., Cormier Y., et al. Phase III trial gemcitabine plus cisplatin versus cisplatin alone with patients with locally advanced or metastatic non-small lung cancer. J Clin Oncol 18 (2000) 122-130
83. Gatzemeir U., von Pawel L., Gottfried M., ten Velde G.P., Mattson K., et al. Phase III comparative study of high dose cisplatin versus a combination of paclitaxel and cisplatin in patients with advanced non-small lung cancer. J Clin Oncol 19 (2001) 2108-2109
84. Bolliger C.T. Introduction to different approaches to intrabronchial treatment. Monaldi Arch Chest Dis 51 (1996) 316-324
85. Bolliger C.T., and Mathur P.N. ERS/ATS statement on interventional pulmonology. Eur Respir J 19 (2002) 356-373
86. Ettinger D.S. Combined modality treatment for stage III a (N2) non-small cell lung cancer: a National Cancer Institute Inter-group Study. Cancer Chemother Pharmacol 42 Suppl. (1998) S71-S74
87. Maivand M.O., and Marthur P.N. Endobronchial cryotherapy. Semin Respir Crit Care Med 18 (1977) 545-554
88. Albin R.J., Soanes W.A., and Gonder M.J. Prospects for cryo-immunotherapy in cases of metastazing carcinoma of prostate. Cryobiology 8 (1971) 271-279
89. Tanaka S. Immunological aspects of cryosurgery in general surgery. Cryobiology 19 (1982) 247-262